CP
MRVI icon

CenterBook Partners’s Maravai LifeSciences MRVI Stock Holding History

CenterBook Partners’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,691,873
Closed -$4.86M – 641
2025
Q3 		$4.86M Buy
1,691,873
+57,365
+4% +$146K 0.24% 112
2025
Q2 		$3.94M Buy
1,634,508
+276,908
+20% +$582K 0.22% 124
2025
Q1 		$3M Buy
1,357,600
+545,674
+67% +$2.16M 0.19% 138
2024
Q4 		$4.42M Buy
+811,926
New +$5.22M 0.26% 114

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CenterBook Partners's MRVI Position: Q4 2025 in Review

CenterBook Partners sold out of Maravai LifeSciences (MRVI) in Q4 2025, closing a stake of 1,691,873 shares — an estimated $4.86M sold.

CenterBook Partners first reported a position in MRVI in Q4 2024 and held it in 4 quarters. The position peaked at $4.86M in Q3 2025. 159 funds tracked by Wall St. Rank hold MRVI as of Q4 2025.

  • CenterBook Partners reported no remaining Maravai LifeSciences position as of Q4 2025 after selling out during the quarter.
  • CenterBook Partners sold 1,691,873 Maravai LifeSciences shares in Q4 2025, an estimated $4.86M.
  • CenterBook Partners first reported a position in Maravai LifeSciences in Q4 2024 and held it in 4 quarters.
  • CenterBook Partners's Maravai LifeSciences position peaked at $4.86M in Q3 2025.
  • 159 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2025.

Based on CenterBook Partners's 13F filing for Q4 2025, filed 11 Feb 2026.